位置:首页 > 蛋白库 > ATRX_CAEEL
ATRX_CAEEL
ID   ATRX_CAEEL              Reviewed;        1359 AA.
AC   Q9U7E0; O02061;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 137.
DE   RecName: Full=Transcriptional regulator ATRX homolog;
DE            EC=3.6.4.12;
DE   AltName: Full=ATP-dependent helicase xnp-1;
DE   AltName: Full=X-linked nuclear protein 1;
GN   Name=xnp-1 {ECO:0000312|WormBase:B0041.7};
GN   ORFNames=B0041.7 {ECO:0000312|WormBase:B0041.7};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10433961; DOI=10.1016/s0378-1119(99)00279-6;
RA   Villard L., Fontes M., Ewbank J.J.;
RT   "Characterization of xnp-1, a Caenorhabditis elegans gene similar to the
RT   human XNP/ATR-X gene.";
RL   Gene 236:13-19(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP   ARG-1130.
RX   PubMed=15328017; DOI=10.1016/j.ydbio.2004.06.009;
RA   Bender A.M., Wells O., Fay D.S.;
RT   "lin-35/Rb and xnp-1/ATR-X function redundantly to control somatic gonad
RT   development in C. elegans.";
RL   Dev. Biol. 273:335-349(2004).
RN   [4]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=15649460; DOI=10.1016/j.ydbio.2004.10.014;
RA   Cardoso C., Couillault C., Mignon-Ravix C., Millet A., Ewbank J.J.,
RA   Fontes M., Pujol N.;
RT   "XNP-1/ATR-X acts with RB, HP1 and the NuRD complex during larval
RT   development in C. elegans.";
RL   Dev. Biol. 278:49-59(2005).
CC   -!- FUNCTION: Required for embryonic development and gonadogenesis. Also,
CC       functions redundantly with the transcriptional repressor lin-35 to
CC       regulate somatic gonad development. {ECO:0000269|PubMed:15328017,
CC       ECO:0000269|PubMed:15649460}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DEVELOPMENTAL STAGE: Expressed in most cells during embryonic
CC       development (PubMed:15328017, PubMed:15649460). First expressed at
CC       around the 100-200 cell stage of embryogenesis (PubMed:15328017,
CC       PubMed:15649460). Expression was absent or reduced in intestinal cell
CC       lineages during this time. Highly expressed in neuronal cells of the
CC       head, ventral nerve cord and tail during the late stages of
CC       embryogenesis (PubMed:15328017). Highly expressed in all dividing cells
CC       after hatching (PubMed:15649460). Highly expressed in the P lineage
CC       during the L1 stage of larval development (PubMed:15649460). During
CC       larval development, mainly expressed in the neurons, but there is also
CC       high expression in the junctional cells of the spermatheca and uterus,
CC       and weak expression in cells of the somatic gonad including the distal
CC       tip cells (PubMed:15328017). {ECO:0000269|PubMed:15328017,
CC       ECO:0000269|PubMed:15649460}.
CC   -!- DISRUPTION PHENOTYPE: Temperature-sensitive with 38% embryonic
CC       lethality at 25 degrees Celsius (PubMed:15649460). A large proportion
CC       of surviving animals are sterile. Surviving animals also have gonad
CC       developmental defects such as defective gonadal arm growth and as a
CC       result irregular distal tip cell migration, and 24% of animals had a
CC       protruding vulva phenotype (PubMed:15649460). Reduced brood size
CC       (PubMed:15328017). Double knockout with lin-35 results in 43% embryonic
CC       lethality (PubMed:15328017). Surviving animals develop slowly, are
CC       small, sterile and display male and female gonad developmental defects
CC       characterized by shorter gonadal arms, fewer germ cells, an everted
CC       vulva phenotype, and failed formation of sheath and spermathecal cells
CC       (PubMed:15328017). RNAi-mediated knockdown of lin-35 or hpl-2 results
CC       in larval arrest at 25 degrees Celsius in an xpn-1 mutant background
CC       (PubMed:15649460). {ECO:0000269|PubMed:15328017,
CC       ECO:0000269|PubMed:15649460}.
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF134186; AAD55361.1; -; mRNA.
DR   EMBL; FO080106; CCD61253.1; -; Genomic_DNA.
DR   PIR; T34036; T34036.
DR   RefSeq; NP_001020958.1; NM_001025787.2.
DR   AlphaFoldDB; Q9U7E0; -.
DR   BioGRID; 37541; 1.
DR   STRING; 6239.B0041.7; -.
DR   iPTMnet; Q9U7E0; -.
DR   EPD; Q9U7E0; -.
DR   PaxDb; Q9U7E0; -.
DR   PeptideAtlas; Q9U7E0; -.
DR   PRIDE; Q9U7E0; -.
DR   EnsemblMetazoa; B0041.7.1; B0041.7.1; WBGene00006961.
DR   GeneID; 172077; -.
DR   KEGG; cel:CELE_B0041.7; -.
DR   UCSC; B0041.7; c. elegans.
DR   CTD; 172077; -.
DR   WormBase; B0041.7; CE17314; WBGene00006961; xnp-1.
DR   eggNOG; KOG1015; Eukaryota.
DR   GeneTree; ENSGT00940000155902; -.
DR   HOGENOM; CLU_000315_11_4_1; -.
DR   InParanoid; Q9U7E0; -.
DR   OrthoDB; 815681at2759; -.
DR   PhylomeDB; Q9U7E0; -.
DR   PRO; PR:Q9U7E0; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00006961; Expressed in embryo and 4 other tissues.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0140658; F:ATP-dependent chromatin remodeler activity; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003678; F:DNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IMP:WormBase.
DR   GO; GO:0008406; P:gonad development; IMP:WormBase.
DR   GO; GO:0040035; P:hermaphrodite genitalia development; IMP:WormBase.
DR   GO; GO:0002009; P:morphogenesis of an epithelium; IMP:WormBase.
DR   GO; GO:0000003; P:reproduction; IMP:WormBase.
DR   GO; GO:0040025; P:vulval development; IMP:WormBase.
DR   Gene3D; 3.40.50.10810; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR044574; ARIP4-like.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR038718; SNF2-like_sf.
DR   InterPro; IPR000330; SNF2_N.
DR   PANTHER; PTHR45797; PTHR45797; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF00176; SNF2-rel_dom; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; DNA damage; DNA repair; DNA-binding; Helicase; Hydrolase;
KW   Nucleotide-binding; Nucleus; Reference proteome.
FT   CHAIN           1..1359
FT                   /note="Transcriptional regulator ATRX homolog"
FT                   /id="PRO_0000074308"
FT   DOMAIN          483..685
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          951..1134
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   REGION          1..402
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          809..891
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           636..639
FT                   /note="DEAH box"
FT   COMPBIAS        18..51
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        73..106
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        121..141
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        149..168
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        175..195
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        202..221
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        228..259
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        269..349
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        373..402
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        832..852
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        853..884
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         496..503
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MUTAGEN         1130
FT                   /note="R->K: In fd2; viable. Gonad morphological defects in
FT                   a lin-35 RNAi background."
FT                   /evidence="ECO:0000269|PubMed:15328017"
FT   CONFLICT        479
FT                   /note="C -> F (in Ref. 2; CCD61253)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1359 AA;  156193 MW;  EB4342547D4F4E64 CRC64;
     MRVGVSESED SDGHVIEDED LEMARQIENE RKEKRAQKLK EKREREGKPP PKKRPAKKRK
     ASSSEEDDDD EEESPRKSSK KSRKRAKSES ESDESDEEED RKKSKSKKKV DQKKKEKSKK
     KRTTSSSEDE DSDEEREQKS KKKSKKTKKQ TSSESSEESE EERKVKKSKK NKEKSVKKRA
     ETSEESDEDE KPSKKSKKGL KKKAKSESES ESEDEKEVKK SKKKSKKVVK KESESEDEAP
     EKKKTEKRKR SKTSSEESSE SEKSDEEEEE KESSPKPKKK KPLAVKKLSS DEESEESDVE
     VLPQKKKRGA VTLISDSEDE KDQKSESEAS DVEEKVSKKK AKKQESSESG SDSSEGSITV
     NRKSKKKEKP EKKKKGIIMD SSKLQKETID AERAEKERRK RLEKKQKEFN GIVLEEGEDL
     TEMLTGTSSQ RKLKSVVLDP DSSTVDEESK KPVEVHNSLV RILKPHQAHG IQFMYDCACE
     SLDRLDTEGS GGILAHCMGL GKTLQVITFL HTVLMHEKIG EKCKRVLVVV PKNVIINWFK
     EFQKWLVDND EELDTIDVNE LDSYKTIEDR RRALKAWHSS KTPSVMIIGY DLFRILTVED
     DPKKKKPKNR NRRLEKAKED FRKYLQNPGP DMVVCDEAHK LKNDDSALSK CMVKILTKRR
     ICLTGTPLQN NLMEYHCMVN FVKPGLLGTK TEFANRFVNI INRGRTKDAS PLEVSFMKRR
     CHVLYDHLKK CVDRKDYRVL TEAIPPKQEY VINVRQTERQ CALYNAFLND IVGDSGLSKR
     LLPDYHMFSR IWTHPYQLVL HEQRMERERV MREDAEEEAD FIDDGDGSES ESEGSFKSGS
     ESDSGKSVVL SSDDEGSSKK KKNGNKPEIK KTAPQKKRKF LNSDDEDEED GEDTAMAILQ
     DGIRQSKRLA GEEADLRDTD TPPEYTGWFA RLGLVKEEDR DDFALSNKLI LLVEIIKKCE
     EIGDKLLVFS QSLESLTLIK RMLEYMAGTG QWFADGHEAL NAEGEETWSW LEGEDYMTID
     GSVQSGKRDA VQTSFNDPLN LRARLMLIST RAGSLGTNMV AANRVIIFDA CWNPSHDTQS
     LFRVYRFGQT KPVYIYRFIA QGTMEERIYK RQVTKESTSM RVVDEAQIQR HYLGNDLTEL
     YQFTPSTFDP DVEISCAPPK DRLLADVIHK NQHAVVDYIE HDTLFANVED EKLTEQEMKD
     AWTDYEKDKS GMPVRAQYAA PPMPGFPNGM IVGQNVQALL QNRMNQGIRV DQMQHDILFK
     ELQKMRIKDA GTAVKIVLLR NLLEQILPYI PDEMRGGMSE FNTHFIRLVH ETDRKMETPA
     DLLRKSLESF KTVIKMVKMI PTCREPLARM TRDYPYLFA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024